Niftas 50mg
Generic: Nitrofurantoinby Intas Pharmaceuticals Ltd

Similar medicines
View allAbout Niftas 50mg
Niftas 50mg is a nitrofurantoin 50 mg tablet made in India by Intas Pharmaceuticals and sold there in strips of 10. Nitrofurantoin is an old urinary antibiotic: it reaches useful levels in the bladder urine but very little in the blood, so it is used for uncomplicated lower urinary tract infections (cystitis) and to prevent repeat infections, not for kidney infections. We sell Niftas 50mg in packs of 60, 90 and 120 tablets; the 120 pack works out at $0.32 a tablet before shipping.
Three facts matter more than the price. First, a bladder infection needs treatment within days, and our delivery takes 7 to 14 business days, so this is not a way to treat an infection you have now; see a doctor or pharmacist locally. Second, the kidney limits differ by country: the US label rules nitrofurantoin out below a creatinine clearance of 60 mL per minute, while the UK label and the MHRA set the line at an eGFR of 45. Third, the drug can harm the lungs, liver and nerves, especially with long-term use, so long courses need a doctor who checks on you. Every figure below is sourced at the end of the page.
Niftas 50mg at a glance
| Active ingredient | Nitrofurantoin 50 mg per tablet (a nitrofuran urinary antibiotic) |
| Brand and maker | Niftas, Intas Pharmaceuticals Ltd, India (PharmEasy, Apollo Pharmacy and Kauvery Meds listings). The carton in our product photo reads "Nitrofurantoin Tablets 50mg", 10 x 10 tablets |
| Regulatory status | Nitrofurantoin is licensed in the US, UK, Canada and Australia, but this Indian Niftas pack is not registered with the FDA, MHRA, TGA or Health Canada. Prescription only in all four countries |
| Usual dose from the label | Treatment: 50 mg four times a day with food for 7 days (UK label; the US label gives 50 to 100 mg four times a day). Long-term prevention: 50 to 100 mg once a day, at bedtime in the US label |
| Half-life | About 30 minutes; urinary excretion usually peaks 2 to 4 hours after a dose (UK SmPC 5.2) |
| Packs | 60, 90 or 120 tablets (Indian strips hold 10) |
| Price per tablet | $0.32 to $0.33 before shipping |
| Delivery | US, UK, Australia and Canada in 7 to 14 business days; $25 shipping under $149, free from $149 |
Price per tablet
As of November 2026; the pack selector shows the current price.
| Pack | Price | Per tablet | Shipping | Per tablet with shipping |
|---|---|---|---|---|
| 60 tablets | $20.00 | $0.33 | $25 | $0.75 |
| 90 tablets | $30.00 | $0.33 | $25 | about $0.61 |
| 120 tablets | $38.00 | about $0.32 | $25 | about $0.53 |
The 60 and 90 packs cost the same per tablet before shipping; the 120 pack is slightly cheaper. With these prices, shipping is most of the cost of a small order. Free shipping starts at $149, which for this product means at least $150 of tablets (for example five 90 packs, 450 tablets), far more than any labelled course (our arithmetic).
How long a pack lasts (our arithmetic from the label doses).
- One 7 day treatment course at 50 mg four times a day is 28 tablets, so the 60 pack holds two courses with 4 tablets left over.
- The NICE 3 day course for women who are not pregnant, at 50 mg four times a day, is 12 tablets.
- The UK label's cover for a urinary procedure (50 mg four times a day on the day and for 3 days after) is 16 tablets.
- Long-term prevention at 50 mg once a night: 60, 90 or 120 nights. At 100 mg a night (two tablets): 30, 45 or 60 nights.
Long-term prevention is the only use where our pack sizes fit, and it is also the use with the highest lung and liver risk (see below). Please do not keep spare tablets to treat future symptoms without a diagnosis: the US label says urine should be cultured before and after treatment.
Compared with US generics and UK supply
| Niftas 50mg (ours) | US generic nitrofurantoin macrocrystals 50 mg | UK nitrofurantoin 50 mg tablets | |
|---|---|---|---|
| Form | Tablet | Capsule | Tablet |
| Maker | Intas, India | Several generic makers (for example Amneal) | Several generic makers (for example Glenmark, Viatris) |
| Licensed where sold | No (Indian pack) | Yes, FDA, prescription only | Yes, MHRA, prescription only (POM) |
| Cost per unit | $0.32 to $0.33 before shipping | About $0.18 a capsule (NADAC $0.17621) | Dispensed on NHS prescription |
US readers. NADAC, the average price US pharmacies pay to buy a medicine, lists generic nitrofurantoin macrocrystals 50 mg capsules at $0.17621 each, 100 mg capsules at $0.25608 and the twice-daily monohydrate/macrocrystals 100 mg capsule at $0.27192 (all effective 21 October 2026, file as of 11 November 2026). There was no Macrobid or Macrodantin brand row. A 28 capsule course at the 50 mg rate is about $4.93 in acquisition cost (our arithmetic), against $45 for our smallest pack with shipping. US generic nitrofurantoin is cheaper, and a local pharmacy can fill it the same day. If you have a US prescription, compare local cash prices first.
Tablet or capsule. The NADAC file lists US nitrofurantoin only as capsules and oral suspension. The UK and Canada license 50 mg tablets. The Indian listings do not say whether Niftas uses the macrocrystal form; the US label notes that "many patients who cannot tolerate microcrystalline nitrofurantoin are able to take nitrofurantoin macrocrystals without nausea". We have no bioequivalence data comparing Niftas with any US, UK or Canadian product.
What the trials say. The Macrobid label reports that, in controlled trials in acute uncomplicated urinary infections, Macrobid 100 mg every 12 hours and Macrodantin 50 mg every 6 hours each gave "approximately 75% microbiologic eradication of susceptible pathogens".
Which dose fits which use
| Use | Label or guideline dose | Niftas 50 tablets |
|---|---|---|
| Acute uncomplicated lower UTI, adults | UK label: 50 mg four times daily for 7 days. US label: 50 to 100 mg four times a day; "the lower dosage level is recommended for uncomplicated urinary tract infections" | 1 tablet four times a day |
| Same, NICE guideline (women who are not pregnant, eGFR 45 or more) | 100 mg modified-release twice a day "(or, if unavailable, 50 mg four times a day) for 3 days" | 1 tablet four times a day for 3 days |
| Severe chronic recurrence (UK label) | 100 mg four times a day for 7 days | 2 tablets four times a day |
| Long-term suppression, adults | UK: 50 to 100 mg once a day. US: "50 to 100 mg at bedtime may be adequate" | 1 or 2 tablets once a day |
| Urinary procedures (UK label) | 50 mg four times daily for the procedure and 3 days after | 1 tablet four times a day |
| Children | By weight: UK 3 mg/kg/day in four doses (over 3 months); US 5 to 7 mg/kg/day in four doses (1 month and over). The UK label suggests the oral suspension for children under 25 kg | Only as a doctor works out; often not suitable |
Our range also lists a Niftas 100mg product; check its form on the strip, because Indian listings show both plain and SR (slow release) Niftas tablets. Which dose and how long are decisions for your doctor.
How to take Niftas 50mg
- With food or milk, every time. The UK label says it "should always be taken with food or milk", which "improves absorption and is important for optimal efficacy" (4.2). The US label says food can increase how much is absorbed.
- Swallow whole. The UK leaflet for nitrofurantoin 50 mg tablets says tablets "should be swallowed whole".
- Spread the four doses through the day. Roughly every 6 hours while awake is our suggestion; the Macrodantin 50 mg arm in the trials described in the Macrobid label was dosed every 6 hours.
- Finish the course your doctor set, even if you feel better (US and UK labels).
- Missed dose: the UK leaflet says "If you remember later on that day, take that day's dose as usual. If you miss a whole day's dose take the normal dose on the next day. Do not take a double dose to make up for a forgotten dose."
- If symptoms do not improve: NICE moves to a second choice antibiotic if there is "no improvement in lower UTI symptoms on first choice taken for at least 48 hours". Contact your doctor at that point.
- Brown urine is expected: urine may turn dark yellow or brown, which the UK leaflet calls "quite normal and not a reason to stop".
Kidney function, age and other groups
Kidneys. Nitrofurantoin needs working kidneys to reach the urine. The labels differ, so here is each one's wording:
- US label (contraindication): "Anuria, oliguria, or significant impairment of renal function (creatinine clearance under 60 mL per minute or clinically significant elevated serum creatinine) are contraindications. Treatment of this type of patient carries an increased risk of toxicity because of impaired excretion of the drug."
- UK label (4.3): contraindicated in "patients suffering from renal dysfunction with an eGFR below 45 ml/minute". UK 4.4: it "may be used with caution as short-course therapy only for the treatment of uncomplicated lower urinary tract infection in individual cases with an eGFR between 30-44 ml/min to treat resistant pathogens, when the benefits are expected to outweigh the risks."
- MHRA, Drug Safety Update, September 2014: "Nitrofurantoin is contraindicated in patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2." and "A short course (3 to 7 days) may be used with caution in certain patients with an eGFR of 30 to 44 ml/min/1.73m2. Only prescribe to such patients to treat lower urinary tract infection with suspected or proven multidrug resistant pathogens when the benefits of nitrofurantoin are considered to outweigh the risks of side effects." The MHRA also advises: "Consider checking renal function when choosing to treat with nitrofurantoin, especially in the elderly."
If you do not know your kidney function, you need a blood test before using this medicine. That is our advice, and it follows from both labels.
Older adults. The US label says spontaneous reports "suggest a higher proportion of pulmonary reactions, including fatalities, in elderly patients" and "an increased proportion of severe hepatic reactions, including fatalities", and that it "may be useful to monitor renal function". The UK label says chronic lung reactions "often occur in elderly patients".
Pregnancy. Both labels rule it out at the end of pregnancy (see below). Earlier in pregnancy, the US label says it "should be used during pregnancy only if clearly needed"; the UK label says it should be used "at the lowest dose as appropriate for a specific indication, only after careful assessment". NICE lists it as a first choice for lower UTI in pregnancy (7 days, eGFR 45 or more) but says "Avoid at term". Pregnancy needs a doctor and a urine culture, not a mail order.
Breastfeeding. US label: nitrofurantoin is found in breast milk in trace amounts, and because of possible serious reactions in infants under one month, "a decision should be made whether to discontinue nursing or to discontinue the drug". UK label: breastfeeding an infant known or suspected to have an enzyme deficiency such as G6PD deficiency "must be temporarily avoided".
Men. NICE says nitrofurantoin "is not recommended for men with suspected prostate involvement because it is unlikely to reach therapeutic levels in the prostate".
Lung, liver and nerve warnings
Lungs. The US label warns, in capitals: "Acute, subacute, or chronic pulmonary reactions have been observed in patients treated with nitrofurantoin. If these reactions occur, nitrofurantoin macrocrystals should be discontinued and appropriate measures taken. Reports have cited pulmonary reactions as a contributing cause of death." Chronic reactions (diffuse interstitial pneumonitis or pulmonary fibrosis, or both) "can develop insidiously. These reactions occur rarely and generally in patients receiving therapy for six months or longer." The US label adds that "pulmonary function may be impaired permanently, even after cessation of therapy". Acute reactions "usually occur within the first week of treatment and are reversible with cessation of therapy".
In April 2023 the MHRA reminded prescribers that "pulmonary reactions may occur with short- or long-term use of nitrofurantoin", after a Coroner's report on a patient who died of acute lung damage and respiratory failure after a 10 day course. Its advice to patients: "seek medical advice if you experience trouble breathing, shortness of breath, a lingering cough, coughing up blood or mucus, or pain or discomfort when breathing."
Liver. US label: "Hepatic reactions, including hepatitis, cholestatic jaundice, chronic active hepatitis, and hepatic necrosis, occur rarely. Fatalities have been reported. The onset of chronic active hepatitis may be insidious, and patients should be monitored periodically for changes in biochemical tests that would indicate liver injury." The UK label adds autoimmune hepatitis to the list. MHRA 2023 signs to report: "yellowing of the skin or eyes, upper right abdominal pain, dark urine and pale or grey-coloured stools, itching or joint pain and swelling".
Nerves. US label: "Peripheral neuropathy, which may become severe or irreversible, has occurred. Fatalities have been reported." Kidney impairment, anaemia, diabetes, electrolyte imbalance, vitamin B deficiency and debilitating disease "may enhance the occurrence". The UK label says "treatment should be stopped at the first signs of neural involvement (paraesthesia)", that is, pins and needles or numbness.
Blood. Haemolytic anaemia has occurred, linked to G6PD deficiency, which the US label says "is found in 10 percent of Blacks and a small percentage of ethnic groups of Mediterranean and Near-Eastern origin". Hemolysis "is an indication for discontinuing" it (US).
Bowel. C. difficile diarrhoea "may range in severity from mild diarrhea to fatal colitis" and "has been reported to occur over two months after the administration of antibacterial agents" (US).
Side effects
Neither label gives a table of rates from controlled trials, so we cannot show a chart by frequency. What the labels say:
- Most frequent: "Nausea, emesis, and anorexia occur most often" (US). Abdominal pain and diarrhoea are less common. The US label says these stomach effects are dose related.
- Nervous system: headache, dizziness, drowsiness, vertigo, nystagmus (jerky eye movements) and weakness (US and UK). Do not drive or use machines if affected (UK 4.7).
- Allergy: rash, itching, hives, angioedema, anaphylaxis, drug fever and joint pain. The US label says hypersensitivity reactions are "the most frequent spontaneously-reported adverse events in worldwide postmarketing experience".
- Serious and listed without a frequency (UK 4.8 "not known"): lung reactions and pulmonary fibrosis, cholestatic jaundice, chronic active hepatitis, hepatic necrosis, peripheral neuropathy, optic neuritis, benign intracranial hypertension, Stevens-Johnson syndrome, DRESS, pancreatitis, interstitial nephritis and blood cell disorders.
- Rare (UK 4.8): aplastic anaemia, collapse and cyanosis.
- Other: brown urine, short-term hair loss, and false positive results on some urine glucose tests. The US label also records that 10 mg/kg/day or more "may, in certain unpredictable instances, produce a slight to moderate spermatogenic arrest with a decrease in sperm count".
When to get urgent help
- Breathing problems: new shortness of breath, cough, chest pain, fever and chills, or coughing up blood. Stop the tablets and get medical help the same day; call emergency services (911 in the US and Canada, 999 in the UK, 000 in Australia) if breathing is hard. The labels say to stop at once; the emergency step is our advice.
- Allergy signs: the UK leaflet says that for "any sudden wheeziness, difficulty in breathing, swelling of the eyelids, face or lips, rash or itching (especially affecting your whole body) STOP TAKING your medicine and go to a doctor immediately". Severe skin reactions with blistering also need urgent care.
- Signs of a kidney infection: fever, shivering, pain in the back or side, or vomiting. Nitrofurantoin "is not indicated for the treatment of pyelonephritis" (US label), and the MHRA says it "should not be used to treat sepsis syndrome secondary to urinary tract infection or suspected upper urinary tract infections". Seek care the same day (our advice).
- Liver signs: yellow skin or eyes, dark urine, pale stools or pain under the right ribs.
- Nerve signs: numbness, tingling or weakness in the hands or feet; stop and contact your doctor (UK 4.4).
- Severe or bloody diarrhoea, even weeks after the course; the US label says to contact your physician "as soon as possible".
- Unusual bruising or bleeding, sore throat or fever, or blue lips or skin: the UK leaflet lists blood cell disorders and cyanosis.
- Taking more than prescribed: the UK leaflet says "Consult your doctor or pharmacist immediately or go to the emergency department of the nearest hospital", taking the pack with you. Tell staff it was nitrofurantoin (Niftas), how much and when.
Who should not take Niftas 50mg
Never take it if (contraindications; the label is named for each):
- allergy to nitrofurantoin or any ingredient of the tablet (US and UK); the UK label adds other nitrofurans;
- kidney function below the label limit: creatinine clearance under 60 mL per minute, anuria or oliguria (US), or eGFR below 45 (UK, MHRA), with the narrow UK exception above;
- pregnancy at term (38 to 42 weeks), during labour and delivery, or when labour is imminent (US); labour and delivery (UK);
- babies under one month (US) or under three months (UK);
- past cholestatic jaundice or liver dysfunction caused by nitrofurantoin (US);
- G6PD deficiency (UK 4.3; in the US label it is a warning about haemolysis);
- acute porphyria (UK).
Use only with caution, or not at all, without a doctor's agreement:
- lung disease, liver problems, nerve disorders or a history of allergies: the UK label says it "should be used with caution" because these "may mask adverse reactions";
- anaemia, diabetes, electrolyte imbalance, debilitating illness or vitamin B (particularly folate) deficiency (UK 4.4);
- long-term use for more than a few weeks: the US label says close lung monitoring "is warranted" and that liver tests should be checked periodically; the MHRA asks that long-term patients "should be closely monitored", especially if elderly;
- suspected kidney infection, a kidney that does not work on one side (UK 4.4), or prostate involvement in men (NICE);
- rare inherited galactose intolerance, total lactase deficiency or glucose-galactose malabsorption: the UK tablets contain lactose and people with these conditions "should not take this medicine". We have not confirmed the excipients in the Indian Niftas tablet; check the pack.
Medicines that interact
- Antacids containing magnesium trisilicate reduce absorption; the US label says not to use them while taking it.
- Probenecid and sulfinpyrazone (gout) can raise blood levels, which "may increase toxicity", and lower urine levels, which "could lessen its efficacy" (US).
- Carbonic anhydrase inhibitors (such as acetazolamide) and medicines that make urine alkaline (such as potassium citrate) can reduce its antibacterial activity (UK 4.5, UK leaflet).
- Quinolone antibiotics: antagonism in the laboratory; the US label says the clinical significance is unknown.
- Oral typhoid vaccine: antibacterials inactivate it (UK 4.5).
- Urine glucose tests: false positives with Benedict's and Fehling's solutions, but not with the glucose enzymatic test (US).
Prescription and legal status
- US: prescription only. FDA-approved nitrofurantoin is sold as capsules and oral suspension; this Indian tablet is not registered with the FDA.
- UK: prescription only (POM in the NHS dictionary of medicines and devices). Nitrofurantoin 50 mg tablets are licensed (for example Glenmark, PL 25258/0362), but this Indian pack is not registered with the MHRA.
- Canada: prescription. Health Canada's Drug Product Database lists a marketed nitrofurantoin 50 mg tablet (AA Pharma, DIN 00319511) and several capsules; this Indian pack is not registered there.
- Australia: Schedule 4, Prescription Only Medicine (healthdirect, for nitrofurantoin capsules); this Indian pack is not registered with the TGA.
- India: the carton in our photo is marked Rx, and Apollo Pharmacy and Kauvery Meds list it as needing a prescription.
The FDA says personal importation of drugs is "illegal in most circumstances", with some enforcement discretion. Talk to your doctor before ordering, and only use this medicine on a diagnosis and prescription.
Buying genuine Niftas
Check that the carton and strip say Niftas, nitrofurantoin tablets 50 mg and Intas, with a batch number and an expiry date that matches between carton and strip. These checks help, but they cannot prove a pack is genuine.
The MHRA warns UK buyers that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." That warning covers this Indian pack. The MHRA advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo".
If a batch causes symptoms, seek medical advice and report it to the MHRA Yellow Card scheme, FDA MedWatch, the TGA or Health Canada, as well as to us.
Delivery
We ship to the US, UK, Australia and Canada in 7 to 14 business days, in plain packaging with tracking. Shipping is $25 on orders under $149 and free from $149. Because of that delivery time, do not rely on this order to treat a urinary infection you have now.
Related guides
Sources
- Nitrofurantoin Capsules USP (Macrocrystals) 50 mg and 100 mg, Amneal, US prescribing information, DailyMed setid 341c75ac-fba5-480d-a221-868c4195cb6f, version 15, effective 14 April 2026: Indications, Contraindications, Warnings, Precautions, Adverse Reactions, Overdosage, Dosage. DailyMed
- Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg, Almatica, US prescribing information, DailyMed setid 8f270a9f-12a1-44d4-bc7e-873613555801, version 27: Dosage, Clinical Studies. DailyMed
- Nitrofurantoin 50 mg Tablets, Glenmark, UK SmPC (PL 25258/0362, revised 2 September 2026), sections 4.1 to 4.9, 5.2, 6.1, and patient leaflet. emc SmPC, emc leaflet
- MHRA Drug Safety Update, volume 8 issue 2, September 2014: nitrofurantoin now contraindicated in most patients with an eGFR of less than 45 ml/min/1.73m2. GOV.UK
- MHRA Drug Safety Update, 26 April 2023: nitrofurantoin, reminder of the risks of pulmonary and hepatic adverse drug reactions. GOV.UK
- NICE guideline NG109, Urinary tract infection (lower): antimicrobial prescribing, 31 October 2018, tables 1 to 3 and recommendation 1.3. NICE
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC) 2026, file as of 11 November 2026: nitrofurantoin macrocrystals 50 mg capsule $0.17621, 100 mg $0.25608, monohydrate/macrocrystals 100 mg $0.27192, all effective 21 October 2026; no Macrobid or Macrodantin rows. data.medicaid.gov
- Health Canada Drug Product Database, nitrofurantoin, checked 16 November 2026 (AA Pharma tablet DIN 00319511, marketed, prescription). Health Canada
- healthdirect Australia, Nitrofurantoin (MLabs) capsules: Schedule 4, Prescription Only Medicine. healthdirect
- NHSBSA dm+d: Nitrofurantoin 50mg tablets 28 tablet (Viatris UK Healthcare), legal category POM, current pack. dm+d browser
- Indian pharmacy listings for Niftas 50 (PharmEasy, Apollo Pharmacy, Kauvery Meds), checked 16 November 2026.
- MHRA, 13 February 2026: 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Niftas is a prescription antibiotic. Use it only after a diagnosis, with a kidney function result, and get medical help straight away for breathing problems, yellow skin or eyes, fever with back pain, or swelling of the face or throat.
Frequently asked questions
What is Niftas 50mg?
Niftas 50mg is a nitrofurantoin 50 mg tablet made in India by Intas Pharmaceuticals and sold there in strips of 10. Nitrofurantoin is a urinary antibiotic used for uncomplicated lower urinary tract infections (cystitis) and to prevent repeat infections. The US label says it is not indicated for kidney infections (pyelonephritis).
Is Niftas the same as Macrobid or Macrodantin?
It contains the same active ingredient, nitrofurantoin, but it is a different product. Macrodantin and US generics are macrocrystal capsules, and Macrobid is a twice-daily 100 mg capsule. Niftas is a 50 mg tablet, and the Indian listings do not say whether it uses the macrocrystal form. We have no bioequivalence data comparing Niftas with any US, UK or Canadian product, and this Indian pack is not registered with the FDA, MHRA, TGA or Health Canada.
How much does Niftas 50mg cost per tablet?
As of November 2026, $0.33 a tablet in the 60 and 90 packs and about $0.32 in the 120 pack, before shipping. With $25 shipping that is $0.75, about $0.61 and about $0.53 a tablet. The pack selector shows the current price. US generic nitrofurantoin 50 mg capsules cost pharmacies about $0.18 each (NADAC, effective 21 October 2026). In our view a US prescription filled locally is usually cheaper; compare local cash prices first.
How do I take Niftas 50mg?
Only as your doctor prescribes. The UK label dose for an acute uncomplicated urinary infection is 50 mg four times daily for 7 days, and NICE uses 50 mg four times a day for 3 days in women who are not pregnant. Always take it with food or milk, swallow it whole, and finish the course. For long-term prevention the labels give 50 to 100 mg once a day, at bedtime in the US label.
Can I use Niftas for a UTI I have right now?
Not from us. Our delivery takes 7 to 14 business days, and a bladder infection needs treatment within days. NICE moves to another antibiotic if symptoms have not improved after at least 48 hours. See a doctor or pharmacist locally, and get same-day care for fever, shivering, back or side pain or vomiting, which can mean a kidney infection.
Can I take Niftas if I have kidney problems?
Often not. The US label makes a creatinine clearance under 60 mL per minute a contraindication. The UK label and the MHRA set the limit at an eGFR below 45, and allow a short course with caution at an eGFR of 30 to 44 only for resistant infections when benefits outweigh risks. Your doctor needs a recent kidney blood test before prescribing it.
Is long-term use of nitrofurantoin safe?
It carries real risks. The US label says chronic lung reactions, including pulmonary fibrosis, occur rarely and generally after six months or more of therapy, and that lung function may be impaired permanently. Liver reactions, including chronic active hepatitis, occur rarely and fatalities have been reported. Long-term use needs a doctor who monitors your lungs and liver tests, especially if you are older.
What are the side effects of Niftas 50mg?
The US label says nausea, vomiting and loss of appetite occur most often. Headache, dizziness, drowsiness, rash and brown urine are also reported. Serious effects include lung reactions, liver injury, nerve damage (numbness or tingling), blood disorders and severe allergic reactions. Stop and get medical help for breathing problems, yellow skin or eyes, or swelling of the face or throat.
Who should not take Niftas 50mg?
Anyone allergic to nitrofurantoin; people below the kidney limit in their label; women at term, in labour or about to give birth; babies under one month (US) or three months (UK); people who had liver problems from nitrofurantoin before (US); and people with G6PD deficiency or acute porphyria (UK). Men with suspected prostate involvement should not use it, according to NICE.
Do I need a prescription for Niftas 50mg?
Yes. Nitrofurantoin is prescription only in the US, UK (POM), Canada and Australia (Schedule 4), and the Niftas carton is marked Rx in India. The FDA says personal importation of drugs is illegal in most circumstances. Talk to your doctor before ordering, and use it only after a diagnosis.
How long does delivery take?
7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping is $25 under $149 and free from $149. Because of that delivery time, this order cannot treat an infection you have now.
Medical References
- 1.Nitrofurantoin Capsules USP (Macrocrystals), Amneal, US prescribing information (DailyMed, v15) — 2026
- 2.Macrobid (nitrofurantoin monohydrate/macrocrystals) US prescribing information (DailyMed, v27) — 2025
- 3.Nitrofurantoin 50 mg Tablets (Glenmark), UK Summary of Product Characteristics — 2026
- 4.MHRA Drug Safety Update: nitrofurantoin contraindicated in most patients with eGFR below 45 ml/min/1.73m2 (September 2014) — 2014
- 5.MHRA Drug Safety Update: nitrofurantoin pulmonary and hepatic adverse reactions — 2023
- 6.NICE NG109: Urinary tract infection (lower): antimicrobial prescribing — 2018
- 7.CMS National Average Drug Acquisition Cost (NADAC) 2026 — 2026
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Niftas 50mg? Tell other buyers how it went.







